Pfizer plans DTC effort to pitch COVID-19 shot safety, joining a fall flurry of vaccine messaging

Pharma companies, industry groups and even the federal government are putting out information about vaccine availability and safety, and Pfizer is set to be the latest to join them

Vaccine marketing messages are flooding media channels this fall. Pharma companies, industry groups and even the federal government are putting out information about vaccine availability and safety, and Pfizer is set to be the latest to join them, according to FiercePharma.

The New York drugmaker told investors it plans to roll out a DTC vaccine campaign as part of its COVID-19 strategy. The company recognizes the importance of increasing public confidence in vaccines, biopharma head Angela Hwang said, and so it’s planning an effort across “multiple channels, including DTC” to stress the importance of vaccinations and provide specific education on COVID-19 vaccine safety.

Pfizer’s Hwang also said the pharma is backing the “Stronger” marketing campaign supported by the biotech industry’s trade association, BIO. That national effort aims to stop the spread of misinformation around vaccines—and stop the war on truth and science.

Another campaign in the works from the U.S. Department of Health and Human Services focuses on the COVID-19 pandemic in general. The planned $250 million campaign looks to help the administration “defeat despair, inspire hope and achieve national recovery,” according to the bid brief.